Impact Venture Capital: Early-Stage Technology Venture Investment Opportunity for Family Offices

Impact Venture Capital is a Silicon Valley-based venture capital firm that invests alongside family offices and corporate venture groups into high growth technology startups. BACKGROUND After managing the venture portfolio for Oracle, Eric Ball and Jack Crawford spun out to launch Impact Venture Capital in 2016. Impact Venture Capital differentiates through its strong partnerships with corporate venture groups of the world's largest companies. Through these partnerships, the innovative VC firm is able to bring additional...
Read More

OXIO Health: Healthcare Post COVID – The New Paradigm, an Opportunity

Company: OXIO is disrupting the healthcare industry with a multifaceted approach to correct the complex flaws across the industry, from billing to patient care and physician motivation Invested: $8 million designing and building a fully operational (SaaS model) and certified ambulatory electronic medical records platform. Team: Seasoned leadership with more than 30 years in healthcare, practice management, patient care, technology, real estate & construction, with multiple companies taken public and successful exits. Vision: To change use of technology...
Read More

Akamara Therapeutics: Reimagining Immunotherapy for Cancer & Rare Disease

Novel scientific insights to unlock the full potential of B cell therapeutics Range of treatment opportunities for cancer immunotherapy and B cell-driven rare diseases Lead program, AT-1965, advancing toward IND and initiation of solid tumor clinical study in 2H2020 Positive pre-IND interaction with FDA; alignment on 2020 IND submission and clinical initiation for AT-1965 Collaborative team with leadership across all biotech disciplines; premier scientific advisors and leading entrepreneur backers Financing underway to fund AT-1965 clinical...
Read More

Choice Housing Investments: Strong Returns in Multifamily Real Estate

Why Choice Housing Investments? The most recent completed quarter, gross annualized Cash on Cash returns were at 12.5% and the Preferred Return was delivered to all investors We continue to see opportunities for investment, yet are stable enough to be selective and not chase deals that have marginal returns Despite the current crisis, multifamily real estate has been a safe harbor. For the past two months, despite COVID and the related crisis, collections and occupancy...
Read More

Ecellix Battery Technologies: eCell™ is a breakthrough technology for the $100B Li-ion Battery Market

BACKGROUND ON COMPANY EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly efficient, re-engineered, small sized turbine engines. Two separate models of these turbines will generate PRIMARY POWER (not just back-up power) for use in the residential, commercial, industrial, and retail sectors. One turbine will be powered by natural gas or any other liquid or gaseous fuel. The other engine will run on any form...
Read More

EPS Holdings: Get Off The Grid – The Future of Power Generation

BACKGROUND ON COMPANY EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly efficient, re-engineered, small sized turbine engines. Two separate models of these turbines will generate PRIMARY POWER (not just back-up power) for use in the residential, commercial, industrial, and retail sectors. One turbine will be powered by natural gas or any other liquid or gaseous fuel. The other engine will run on any form...
Read More

Verdego Aero: Leading the Electrification of the $1.2T Aerospace Industry

Background on Company The aerospace market is being disrupted by electrification, creating opportunities for new types of aircraft, improved economics, and lower emissions. Erik Lindbergh and a team of experienced technology and business leaders founded VerdeGo Aero to enable the next generation of clean, quiet, flight. VerdeGo Aero’s electric powertrains deliver significant competitive advantages for aircraft manufacturers focused on high performance and low operating costs. Customers in multiple aerospace market segments are leveraging VerdeGo Aero’s...
Read More

RMS: Addressing Diabetes, the Fastest Growing Disease in the World

BACKGROUND ON COMPANY Revolutionary cell therapy targeting a cure for both Type 1 and Type 2 diabetes Successful demonstration of curative properties in animal models, with a human clinical trial targeted for 2021 Utilization of ethically derived human induced pluripotent stem cells (iPSC, non-embryonic), which have the potential for significant scaleup to reach greater patient populations while avoiding ethical concerns RMS has been highly successful in obtaining significant non-dilutive capital from sources such as the...
Read More

AgVest: Farmland Investing Provides Reliable Returns In Uncertain Times

Chris Brawner has been involved in over $650M in farmland investments over the past decade. Discover the benefits of investing in farmland during this webinar. By 2030 the global population is expected to be +8 Billion. The developing world's middle class continues to update its diet which includes more protein, which will take more grains to provide. The world's farmland acres are finite and continue to decrease due to industrialization and urbanization. In times of...
Read More
1 2 3 4